cellular therapy reporting to cibmtr – part 2

NEW DM ONBOARDING FEB 2021 | 1 .

The CIBMTR® (Center for International Blood and Marrow Transplant Research®) is a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW).

Cellular Therapy Reporting to CIBMTR – Part 2Tiffany Hunt, MS, CCRPJaime Santi, MT(ASCP) SBB

There are no conflicts of interest to disclose.


Pre-Work


Questions on eLearning?


Agenda• Practice combined follow up reporting scenarios


TermsTerm DefinitionCT Cellular therapyHCT Hematopoietic cell transplantDCI Donor cellular infusion (a type of CT)DLI Donor lymphocyte infusion (a type of DCI)Pre-CTED Pre-Cellular Therapy Essential DataPost-CTED Post-Cellular Therapy Essential Data


Combined follow up


Infusion to Infusion

Infusion #1HCT1/15/2017 100d 6mo 1yr 3yr

24002402

Infusion #2CAR-T8/5/2019

40002402

100d 6mo

Reporting continues chronologically

This 100d F2450 is not a repeat of the previously completed 100d F2450. These forms capture the timepoint from Infusion #2 thru D+100

2450 2450 2450 2450

1yr

41002450

41002450

41002450

2yr

2450


Activity 8: Combined follow up• Use CRID from Activity 1

– The post-HCT cellular therapy

• Complete the F4000 – Everyone use the CAR-T example this time – We need a genetically modified cellular therapy to highlight

combined follow up


Activity 8: Combined follow up


Activity 8: Combined follow up• Result

• Take 10 minutes

Forms paired at the time points


Form Instruction Manuals


https://www.cibmtr.org/manuals/fim/1/en/topic/cellular-therapy


Contact the CIBMTR Center Support

cellular therapy reporting to cibmtr – part 2

Documents